| Oligometastatic Carcinoma studied in …STUDIED_INderived10 of 19show all (up to 200) |
|---|
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05673148Phase 2 · recruiting Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053152Phase 2 · active not recruiting Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534438Phase 2 · recruiting A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975516Phase 2 · terminated Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04190446Phase 2 · active not recruiting A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578116Phase 3 · not yet recruiting Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496959Phase 2 · active not recruiting 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study · condition mapped ONTOLOGY_EXACT · 19 trials mapped (17 active) | — | — | Oligometastatic Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |